Core Insights - Glass House Brands Inc. is accelerating its expansion plans for 2026 due to positive results from previous developments and anticipated cannabis reform actions [1][8] Production Capacity - The company has returned to full production capacity in its existing greenhouses and completed the buildout of the first third of Greenhouse 2, marking the highest planted acreage in its history [2] - Greenhouse 2 will add approximately 300,000 lbs. of biomass in annual production capacity, with full planting expected by the second quarter of 2026 [3] New Developments - A light retrofit and buildout of Greenhouse 4 has commenced, targeting international CBD and hemp markets, with plans to supply the reimbursable CBD market under President Trump's Executive Order [4][6] - The company is preparing for new business opportunities arising from cannabis rescheduling and the creation of a Medicare reimbursement program for CBD [6] Market Position - Glass House is positioned to capitalize on growth opportunities in the U.S. CBD market, with existing CBD/low THC strains that can comply with new federal regulations [6] - The company is engaged in developing medicinal cannabinoids through a partnership with the University of California Berkeley, aiming to be a leading supplier in pharmaceutical and consumer packaged goods markets [6] Expansion Strategy - The company is accelerating its expansion efforts by planning production in two additional greenhouses and targeting markets outside of California [8] - The expansion is driven by confidence in restoring existing operations and developing new business opportunities, including international exports [8]